Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C13orf34 |
| Upstream (Parents) |
|---|
| (<<) TTK → C13orf34 |
| (<<) TOP2A → C13orf34 |
| (<<) AURKB → C13orf34 |
| (<<) RFC3 → C13orf34 |
| (<<) MAPRE1 → C13orf34 |
| Downstream (Children) |
|---|
| C13orf34 → STEAP1 (>>) |
| C13orf34 → NEK3 (>>) |
| C13orf34 → GTF2F2 (>>) |
| C13orf34 → OLFM4 (>>) |
| C13orf34 → FUT7 (>>) |
| C13orf34 → EDN3 (>>) |
| C13orf34 → HR (>>) |
| C13orf34 → IMPG2 (>>) |
| C13orf34 → RLN2 (>>) |
| C13orf34 → GNB5 (>>) |
| C13orf34 → DSCR6 (>>) |
| C13orf34 → RFC3 (>>) |
| C13orf34 → DLEU2L///DLEU2 (>>) |
| C13orf34 → NUDT15 (>>) |
| C13orf34 → ALCAM (>>) |
| C13orf34 → LRCH1 (>>) |
| C13orf34 → ELF1 (>>) |
| C13orf34 → CAP2 (>>) |
| C13orf34 → RNASEH2B (>>) |
